Laboratorios Richmond S.A.C.I.F., together with its subsidiaries, develops, manufactures, and sells pharmaceutical products in Latin America, Africa, Asia, and the Middle East. It offers antiretroviral drugs for the treatment of human immunodeficiency virus; oncology and oncohematology drugs; cardiometabolism drugs, including antihypertensive, hypocholesterolemic, platelet antiaggregants, and hypoglycemic drugs; and neurological and psychiatric drugs, such as analgesics, antipsychotics, antidepressants, anti-dementia, antiepileptics, and hypnotic drugs, as well as drugs for the treatment of multiple sclerosis. The company was incorporated in 1959 and is headquartered in Buenos Aires, Argentina.
Frequently asked questions
What sector does Laboratorios Richmond SACIF (RICH) operate in?
Laboratorios Richmond SACIF belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Laboratorios Richmond SACIF (RICH) current stock price?
As of the latest data, Laboratorios Richmond SACIF stock price is ARS 1,550.00, with a previous close of ARS 1,535.00. Laboratorios Richmond SACIF gained ARS 15.00 in the last trading session, representing a 0.98% increase.
What is Laboratorios Richmond SACIF (RICH) current market capitalization?
Laboratorios Richmond SACIF market cap is approximately 103.21 billion.
What is Laboratorios Richmond SACIF (RICH) Earnings Per Share (EPS)?
The trailing EPS is ARS 198.73.
What is Laboratorios Richmond SACIF (RICH) Price-to-Earnings (P/E) ratio?
Laboratorios Richmond SACIF current P/E ratio is 7.8.
Does Laboratorios Richmond SACIF (RICH) pay dividends?
No. Laboratorios Richmond SACIF does not pay a dividend.
What is Laboratorios Richmond SACIF (RICH) beta (volatility) score?
Laboratorios Richmond SACIF has a beta of -0.656, indicating lower volatility than the overall market.
